TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials
[...]both decreased the stent thrombosis rate compared with clopidogrel, prasugrel being the more effective of the two.Ticagrelor use was also associated with improved all-cause mortality compared with clopidogrel; no difference was found between prasugrel and clopidogrel.
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2016-11, Vol.68 (18), p.B41-B42 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | B42 |
|---|---|
| container_issue | 18 |
| container_start_page | B41 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 68 |
| creator | Shah, Rahman Hwang, Inyong Hwang Nayyar, Mannu Slomka, Teresa Rashid, Abdul |
| description | [...]both decreased the stent thrombosis rate compared with clopidogrel, prasugrel being the more effective of the two.Ticagrelor use was also associated with improved all-cause mortality compared with clopidogrel; no difference was found between prasugrel and clopidogrel. |
| doi_str_mv | 10.1016/j.jacc.2016.09.348 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1834405437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109716356704</els_id><sourcerecordid>4234727961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2287-b509a785bf7cea24899ea0dd23db87b404c4e84eca929f840a15cf5b750d0b2d3</originalsourceid><addsrcrecordid>eNp9UU2LFDEQbUTBcfUPeAp47raSTiaJiDAM6wesH-zOHjyFdFKNme3pjEnPSvsn_MumGUHw4KmK4r2qV-9V1XMKDQW6frlv9ta5hpW-Ad20XD2oVlQIVbdCy4fVCmQragpaPq6e5LwHgLWielX92m13Zc7JNQ52CvdILvs-OOtmYkdPbmyP00xiT2KyA_nCvlJGwvgtdGGKKZeWbNxpQuJiiqNNM8nz6FM84CuyGcnt0dsJPfmE04-Y7shHnGy9Ge0w55CXrdflSDyEnwWzS8EO-Wn1qC8Fn_2pF9Xt28vd9n199fndh-3mqnaMKVl3ArSVSnS9dGgZV1qjBe9Z6zslOw7ccVQcndVM94qDpcL1opMCPHTMtxfVi_PeY4rfT5gns4-nVJRlQ1XLOQjeyoJiZ5RLMeeEvTmmcChvGgpmMd7szWK8WYw3oE0xvpBen0lY9N8HTCa7gKNDHxK6yfgY_k9_8w_dDWEskQx3OGP-K9NkZsDcLMkuwdJ1K9YSePsbyhug3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834405437</pqid></control><display><type>article</type><title>TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials</title><source>Elsevier ScienceDirect Journals Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Shah, Rahman ; Hwang, Inyong Hwang ; Nayyar, Mannu ; Slomka, Teresa ; Rashid, Abdul</creator><creatorcontrib>Shah, Rahman ; Hwang, Inyong Hwang ; Nayyar, Mannu ; Slomka, Teresa ; Rashid, Abdul</creatorcontrib><description>[...]both decreased the stent thrombosis rate compared with clopidogrel, prasugrel being the more effective of the two.Ticagrelor use was also associated with improved all-cause mortality compared with clopidogrel; no difference was found between prasugrel and clopidogrel.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2016.09.348</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Cardiology ; Cardiovascular ; Internal Medicine ; Mortality</subject><ispartof>Journal of the American College of Cardiology, 2016-11, Vol.68 (18), p.B41-B42</ispartof><rights>2016</rights><rights>Copyright Elsevier Limited Nov 1, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2287-b509a785bf7cea24899ea0dd23db87b404c4e84eca929f840a15cf5b750d0b2d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109716356704$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Shah, Rahman</creatorcontrib><creatorcontrib>Hwang, Inyong Hwang</creatorcontrib><creatorcontrib>Nayyar, Mannu</creatorcontrib><creatorcontrib>Slomka, Teresa</creatorcontrib><creatorcontrib>Rashid, Abdul</creatorcontrib><title>TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials</title><title>Journal of the American College of Cardiology</title><description>[...]both decreased the stent thrombosis rate compared with clopidogrel, prasugrel being the more effective of the two.Ticagrelor use was also associated with improved all-cause mortality compared with clopidogrel; no difference was found between prasugrel and clopidogrel.</description><subject>Acute coronary syndromes</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Internal Medicine</subject><subject>Mortality</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9UU2LFDEQbUTBcfUPeAp47raSTiaJiDAM6wesH-zOHjyFdFKNme3pjEnPSvsn_MumGUHw4KmK4r2qV-9V1XMKDQW6frlv9ta5hpW-Ad20XD2oVlQIVbdCy4fVCmQragpaPq6e5LwHgLWielX92m13Zc7JNQ52CvdILvs-OOtmYkdPbmyP00xiT2KyA_nCvlJGwvgtdGGKKZeWbNxpQuJiiqNNM8nz6FM84CuyGcnt0dsJPfmE04-Y7shHnGy9Ge0w55CXrdflSDyEnwWzS8EO-Wn1qC8Fn_2pF9Xt28vd9n199fndh-3mqnaMKVl3ArSVSnS9dGgZV1qjBe9Z6zslOw7ccVQcndVM94qDpcL1opMCPHTMtxfVi_PeY4rfT5gns4-nVJRlQ1XLOQjeyoJiZ5RLMeeEvTmmcChvGgpmMd7szWK8WYw3oE0xvpBen0lY9N8HTCa7gKNDHxK6yfgY_k9_8w_dDWEskQx3OGP-K9NkZsDcLMkuwdJ1K9YSePsbyhug3Q</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Shah, Rahman</creator><creator>Hwang, Inyong Hwang</creator><creator>Nayyar, Mannu</creator><creator>Slomka, Teresa</creator><creator>Rashid, Abdul</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20161101</creationdate><title>TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials</title><author>Shah, Rahman ; Hwang, Inyong Hwang ; Nayyar, Mannu ; Slomka, Teresa ; Rashid, Abdul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2287-b509a785bf7cea24899ea0dd23db87b404c4e84eca929f840a15cf5b750d0b2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute coronary syndromes</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Internal Medicine</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, Rahman</creatorcontrib><creatorcontrib>Hwang, Inyong Hwang</creatorcontrib><creatorcontrib>Nayyar, Mannu</creatorcontrib><creatorcontrib>Slomka, Teresa</creatorcontrib><creatorcontrib>Rashid, Abdul</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, Rahman</au><au>Hwang, Inyong Hwang</au><au>Nayyar, Mannu</au><au>Slomka, Teresa</au><au>Rashid, Abdul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2016-11-01</date><risdate>2016</risdate><volume>68</volume><issue>18</issue><spage>B41</spage><epage>B42</epage><pages>B41-B42</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>[...]both decreased the stent thrombosis rate compared with clopidogrel, prasugrel being the more effective of the two.Ticagrelor use was also associated with improved all-cause mortality compared with clopidogrel; no difference was found between prasugrel and clopidogrel.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2016.09.348</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2016-11, Vol.68 (18), p.B41-B42 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1834405437 |
| source | Elsevier ScienceDirect Journals Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Acute coronary syndromes Cardiology Cardiovascular Internal Medicine Mortality |
| title | TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A59%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TCT-104%20Relative%20Efficacy%20and%20Safety%20of%20oral%20P2Y12%20inhibitors%20in%20Acute%20coronary%20syndrome:%20An%20Updated%20Network%20Meta-Analysis%20of%20Randomized%20Trials&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Shah,%20Rahman&rft.date=2016-11-01&rft.volume=68&rft.issue=18&rft.spage=B41&rft.epage=B42&rft.pages=B41-B42&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2016.09.348&rft_dat=%3Cproquest_cross%3E4234727961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834405437&rft_id=info:pmid/&rft_els_id=1_s2_0_S0735109716356704&rfr_iscdi=true |